Fast Five Quiz: Coronary Artery Atherosclerosis Management

Arnold S. Baas, MD


May 06, 2022

According to cholesterol management guidelines from the American Heart Association/American College of Cardiology, high-intensity statin therapy (or the maximally tolerated statin) is recommended for patients with ASCVD. Greater reductions in LDL-C levels equate greater reductions in cardiovascular risk. Other guideline recommendations include:

  • In patients 40-75 years of age with diabetes and LDL-C ≥ 70 mg/dL (≥ 1.8 mmol/L), a moderate-intensity statin should be prescribed without calculating 10-year ASCVD risk

  • Moderate-intensity statins are recommended for patients with a ≥ 7.5% 10-year risk for ASCVD

  • In very high-risk ASCVD (a history of multiple major ASCVD events or one major ASCVD event and multiple high-risk conditions), an LDL-C threshold of 70 mg/dL (1.8 mmol/L) should be used to consider addition of nonstatins to statin therapy

Learn more about the management of coronary artery sclerosis.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.